Anticonvulsants (gabapentin 300 mg/day) vs placebo
Adverse effects: drowsiness (gabapentin alone) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether anticonvulsants (gabapentin 300 mg/day) changes adverse effects: drowsiness (gabapentin alone) compared with placebo (very low certainty).
1 finding from 1 review
- Interventions for treating burning mouth syndrome 2016 · Cochrane All outcomesshort-term (up to 3 months)RR 31.95 [1.84, 553.64]1 study · 80 participantsVery low